Literature DB >> 11818777

Xenon does not impair the responsiveness of cardiac muscle bundles to positive inotropic and chronotropic stimulation.

Sylvia C Schroth1, Ulrich Schotten, Orkide Alkanoglu, Matthias S Reyle-Hahn, Peter Hanrath, Rolf Rossaint.   

Abstract

BACKGROUND: Most volatile anesthetics exhibit a direct myocardial depressant effect. This side effect often limits their applicability in patients with impaired cardiac function. Xenon is a new gaseous anesthetic that did not show any adverse cardiovascular effects in clinical and experimental studies. The authors tested the hypothesis that xenon does not affect myocardial contractility or the positive inotropic effect of isoproterenol, calcium, and increase in pacing rate in isolated guinea pig ventricular muscle bundles.
METHODS: Thin ventricular muscle bundles from guinea pig hearts with a mean diameter of 0.4-0.45 mm were prepared under stereomicroscopic control. Force of contraction and contraction times were studied in muscles superfused with medium equilibrated with either 65% xenon and 35% oxygen (xenon group), 1.2% isoflurane in oxygen (isoflurane group), or 65% nitrogen and 35% oxygen (control group). In addition, the positive inotropic effects of calcium, isoproterenol (10(-10)-3 x 10(-8) M) and increasing frequency (0.5-2 Hz) were studied during xenon and isoflurane exposure.
RESULTS: In contrast to isoflurane, xenon did not alter myocardial force of contraction or contraction times. The positive inotropic effect of isoproterenol, calcium, and increasing pacing frequencies did not differ between the muscles exposed to xenon and the control group. Isoflurane elicited the expected negative inotropic effect (30% reduction of force of contraction) but did not impair the response to inotropic stimuli.
CONCLUSIONS: Xenon does not alter myocardial contractility and the response to inotropic stimuli such as calcium, isoproterenol, or increase in pacing frequency in isolated guinea pig ventricular muscle bundles.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11818777     DOI: 10.1097/00000542-200202000-00030

Source DB:  PubMed          Journal:  Anesthesiology        ISSN: 0003-3022            Impact factor:   7.892


  4 in total

1.  Early cognitive function, recovery and well-being after sevoflurane and xenon anaesthesia in the elderly: a double-blinded randomized controlled trial.

Authors:  Jan Cremer; Christian Stoppe; Astrid V Fahlenkamp; Gereon Schälte; Steffen Rex; Rolf Rossaint; Mark Coburn
Journal:  Med Gas Res       Date:  2011-05-18

2.  Safety and feasibility of xenon as an adjuvant to sevoflurane anaesthesia in children undergoing interventional or diagnostic cardiac catheterization: study protocol for a randomised controlled trial.

Authors:  Sarah Devroe; Jurgen Lemiere; Marc Van de Velde; Marc Gewillig; Derize Boshoff; Steffen Rex
Journal:  Trials       Date:  2015-03-04       Impact factor: 2.279

Review 3.  Noble Gases Therapy in Cardiocerebrovascular Diseases: The Novel Stars?

Authors:  Jiongshan Zhang; Wei Liu; Mingmin Bi; Jinwen Xu; Hongzhi Yang; Yaxing Zhang
Journal:  Front Cardiovasc Med       Date:  2022-03-16

4.  Evaluation of hemodynamic effects of xenon in dogs undergoing hemorrhagic shock.

Authors:  Ruben C Franceschi; Luiz Malbouisson; Eduardo Yoshinaga; Jose Otavio Costa Auler; Luiz Francisco Poli de Figueiredo; Maria Jose C Carmona
Journal:  Clinics (Sao Paulo)       Date:  2013       Impact factor: 2.365

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.